The BIOBASE brand, founded in 1997 (Germany), from 10 sister brands and 2617 competing brands. BIOBASE is owned by QIAGEN, listed on the stock exchange of New York The International Securities Identification Number (ISIN) of QIAGEN is NL0012169213. The sector of BIOBASE is Medical Diagnostics & Research.
Investment simulator :
Portfolio valuation
QIAGEN
(BIOBASE)
over 5 years*
USD 43.74